Osteoporosis medications may extend life after a fracture
New data suggests that long-term osteoporosis medications are associated with a lower risk of death after a fracture. The results, from approximately 50,000 individuals in a nationwide Taiwanese database from 2009 through 2018, indicate that alendronate/risedronate, denosumab and zoledronic acid all lead to a 17% to 22% lower risk of death after fracture compared with … Read more